Related references
Note: Only part of the references are listed.Challenges for Rapid Molecular HIV Diagnostics
Marco L. Schito et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
A case-control study of factors associated with resolution of hepatitis C viremia in former blood donors
Leslie H. Tobler et al.
TRANSFUSION (2010)
Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and Reinfection
Kimberly Page et al.
JOURNAL OF INFECTIOUS DISEASES (2009)
Temporal Trends in Spatial Access to Pharmacies that Sell Over-the-Counter Syringes in New York City Health Districts: Relationship to Local Racial/Ethnic Composition and Need
Hannah L. F. Cooper et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2009)
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Dongliang Ge et al.
NATURE (2009)
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
David L. Thomas et al.
NATURE (2009)
Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis
Rami Moucari et al.
GASTROENTEROLOGY (2008)
Changing HCV genotypes distribution in Poland - Relation to source and time of infection
Slawomir Chlabicz et al.
JOURNAL OF CLINICAL VIROLOGY (2008)
Relationship between T cell activation and CD4(+) T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy
Peter W. Hunt et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Hepatitis C vaccine: supply and demand
G. Thomas Strickland et al.
LANCET INFECTIOUS DISEASES (2008)
Evaluation of a new-generation line-probe assay that detects 5′ untranslated and core regions to genotype and subtype hepatitis C virus
Rohan Nadarajah et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2007)
Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: Availability and outcomes
Keith G. Heinzerling et al.
JOURNAL OF SUBSTANCE ABUSE TREATMENT (2007)
Injection drug users in the United States, 1979-2002 - An aging population
Gregory L. Armstrong
ARCHIVES OF INTERNAL MEDICINE (2007)
Increasing syringe access and HIV prevention in California: Findings from a survey of local health jurisdiction key personnel
Thomas J. Stopka et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2007)
Community characteristics associated with HIV risk among injection drug users in the san francisco bay area: A multilevel analysis
Ricky N. Bluthenthal et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2007)
Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States
Omana V. Nainan et al.
GASTROENTEROLOGY (2006)
Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates
A Katsoulidou et al.
JOURNAL OF VIRAL HEPATITIS (2006)
Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
P Simmonds et al.
HEPATOLOGY (2005)
HIV among injection drug users in large US metropolitan areas, 1998
SR Friedman et al.
JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE (2005)
Molecular epidemiology of hepatitis C among drug users in Flanders, Belgium:: association of genotype with clinical parameters and with sex- and drug-related risk behaviours
C Matheï et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium:: The GEMHEP GenoCII Study
C Payan et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Effect of hepatitis C virus (HCV) genotype on HCV and HIV-1 disease
TW Yoo et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Spread of hepatitis C virus among European injection drug users infected with HIV: A phylogenetic analysis
L van Asten et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Differences in treatment outcome for hepatitis C among ethnic groups
MJ Hepburn et al.
AMERICAN JOURNAL OF MEDICINE (2004)
Frequent hepatitis C virus superinfection in injection drug users
BL Herring et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites
AJ Muir et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Multiple infections with different HCV genotypes:: prevalence and clinical impact
M Schröter et al.
JOURNAL OF CLINICAL VIROLOGY (2003)
Influence of age and date of infection on distribution of hepatitis C virus genotypes and fibrosis stage
MA Serra et al.
JOURNAL OF VIRAL HEPATITIS (2003)
Changing molecular epidemiology of hepatitis C virus infection in northeast Italy
G Dal Molin et al.
JOURNAL OF MEDICAL VIROLOGY (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
HIV risk behaviors in African-American drug injector networks: implications of injection-partner mixing and partnership characteristics
RA Johnson et al.
ADDICTION (2002)
Epidemiological dynamics of hepatitis C virus among 747 German individuals:: New subtypes on the advance
M Schröter et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Epidemiological changes in hepatitis C virus genotypes in France: evidence in intravenous drug users
M Bourliere et al.
JOURNAL OF VIRAL HEPATITIS (2002)
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
MP Manns et al.
LANCET (2001)
African Americans with genotype 1 treated with interferon for chronic hepatitis C have a lower end of treatment response than Caucasians
JL Kinzie et al.
JOURNAL OF VIRAL HEPATITIS (2001)
The natural history of hepatitis C virus infection - Host, viral, and environmental factors
DL Thomas et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Share Paper
